Gianluca Spitaleri

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

Stefania Rizzo, Francesco Petrella, Valentina Buscarino et al. · European Radiology · 2015 · 262 citations

Oncology, Alk Mutations, Medicine +9

The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano et al. · European Journal of Cancer · 2010 · 179 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +7

Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib

Justin F. Gainor, Daniel Shao-Weng Tan, Tomasso De Pas et al. · Clinical Cancer Research · 2015 · 178 citations · Full text

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Thomas Eigentler, Benjamin Weide, Filippo de Braud et al. · Clinical Cancer Research · 2011 · 149 citations · Full text

Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

Tommaso De Pas, Francesca Toffalorio, Michela Manzotti et al. · Journal of Thoracic Oncology · 2011 · 136 citations · Full text

Medicine, Receptor Tyrosine Kinase, Pathology +7